Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001732369-26-000010

CHIEF EXECUTIVE OFFICER acquired 55,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Seehra Jasbir · CHIEF EXECUTIVE OFFICER

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-04-02 Exercise or conversion : show line 1 in the form +55,000 $0.30 $16,500 440,708 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-04-02 Exercise or conversion : show line 2 in the form Employee Stock Option (Right to Buy) −55,000 197,444 D
Loading xslF345X06/form4-04062026_040401.xml…